Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Merck and Eisai cull late-stage study for head and neck cancer therapy
07:58am, Friday, 25'th Aug 2023
Merck & Co Inc (NYSE:MRK) and research partner Eisai said they are halting a late-stage trial that used a combination of drugs to treat a type of head and neck cancer after it didn't result in an over
Merck and Eisai say late-stage trial of treatment for head and neck cancer did not meet goals
06:52am, Friday, 25'th Aug 2023
Merck & Co. Inc. MRK, -1.66% and Eisai Co. Ltd. 4523, -1.23% ESAIY, -1.95% said Friday a late-stage trial of a treatment for head and neck cancer failed to meet its main goals and the companies have d
Merck, Eisai discontinue late-stage study for cancer therapy
06:47am, Friday, 25'th Aug 2023
Merck & Co and partner Eisai said on Friday they will shut down a late-stage study testing an experimental combination therapy for a type of head and neck cancer after an interim analysis showed it fa
Will Keytruda Remain Merck's (MRK) Key Top-Line Driver?
12:47pm, Wednesday, 23'rd Aug 2023
With continued label expansion into new indications, particularly earlier-line launches, Merck's (MRK) Keytruda is expected to remain a key top-line driver.
Health care sector holding up well: Strategist says look at United Healthcare, Merck, Amgen
02:22pm, Tuesday, 22'nd Aug 2023
Why are UnitedHealth (UNH), Merck & Company (MRK), Johnson & Johnson (JNJ), and Amgen (AMGN), this strategist's top health care stock picks? Freedom Capital Markets Chief Global Strategist Jay Woods j
Merck's (MRK) Welireg Meets Renal Cell Carcinoma Study Goals
03:02pm, Monday, 21'st Aug 2023
Based on interim data from a late-stage study, Merck's (MRK) Welireg achieves statistically significant improvements in one of the study's dual endpoints of progression-free survival.
Is Merck's Long-Term Investment Brilliance Unshaken By COVID-19 Drug Sales Slump?
01:57pm, Monday, 21'st Aug 2023
On August 1, Merck released its financial report for the second quarter of 2023, which showed excellent results. Merck's revenue for the second quarter of 2023 was $15.04 billion, up 3.8% from the pre
The 3 Most Undervalued Pharma Stocks to Buy Now: August 2023
05:30am, Monday, 21'st Aug 2023
There are sectors in the economy that go through an extended period of trending sideways to lower. A good example is the pharmaceutical sector.
Why startups are investing millions to make drugs and semiconductors in space
09:00am, Sunday, 20'th Aug 2023
The market for materials manufactured in space could reach $10 billion by 2030, according to an estimate from a McKinsey analyst.
Despite The One-Time Charge, Merck Is Still A Buy
05:26am, Sunday, 20'th Aug 2023
Merck's revenues have increased by 31% over the last decade, driven by sales volume, price increases, and M&A activity. The company has a strong track record of increasing dividends annually for the p
Pharma stocks are typically shunned by Wall St. when people feel confident about economy: Jim Cramer
07:32pm, Wednesday, 16'th Aug 2023
'Mad Money' host Jim Cramer talks the Pharma industry facing off against the federal government over IRA provisions.
What pharma brands will be impacted by Medicare price negotiations
02:59pm, Monday, 14'th Aug 2023
Jared Holz, Mizuho healthcare strategist, joins 'The Exchange' to discuss Medicare drug price negotiations, the M&A impact of government intervention into drug pricing, and more.
Buy Merck (MRK) Stock Now to Ride a Wave Higher in Healthcare
03:44pm, Friday, 11'th Aug 2023
Merck (NYSE: MRK ) has consistently delivered impressive financial results, built a robust product portfolio, and demonstrated an unwavering commitment to research and development. Given this, I think
Pharma ETFs in Focus Post Q2 Earnings
01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.
The 3 Best ESG Stocks to Buy in August
09:20pm, Thursday, 10'th Aug 2023
It's a common assumption that the best ESG (environmental, social, governance) stocks to buy may be profitable for your inner wellbeing but not necessarily for your portfolio. After all, doing the rig
